VNDA Articles, Vanda Pharmaceuticals Inc. - From 04/03/24

U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining over 0.5% on Wednesday. The Dow traded up 0.18% to 39,241.00 wh...

Tuesday, the FDA approved Vanda Pharmaceuticals Inc’s (NASDAQ:VNDA) Fanapt (iloperidone) tablets for the acute treatment of manic o...

Shares of Cal-Maine Foods, Inc. (NASDAQ: CALM) rose sharply in today’s pre-market trading after the company reported upbeat results for its ...

NEW YORK, March 23, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Vanda Pharmaceutical Inc. ("Vanda"?...

NEW YORK, March 15, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Vanda Pharmaceuticals Inc. ("Vanda"...

Vanda Pharmaceuticals Inc (NASDAQ: VNDA) has acquired U.S. and Canadian rights to Ponvory (ponesimod) from Actelion Pharmaceuticals Ltd, ...

WASHINGTON, Dec. 7, 2023 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ:VNDA) today announced that it has acquired U.S. and Canadian ri...